CTRI/2019/01/017085尚未招募未知
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing in Lung cancer
TMAI PAI ENDOWMENT CHAIR0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Newly diagnosed cases of lung cancer.
- •2.Age <70 years and > 18 years of age.
- •3.Patients who are willing to give informed consent.
- •4.Patients who have not received Chemotherapy or Radiotherapy for treatment before.
排除标准
- •1.Age more than 70 and less than 18 years of age.
- •2.Patients not willing to give informed consent.
- •3.Patients who have received Chemotherapy or Radiotherapy for treatment before.
研究者
相似试验
尚未招募
不适用
Identification of Genetic Changes in Indian Lung Cancer PatientsCTRI/2019/12/022284DST INSPIRE Fellowship
招募中
不适用
A Phase III Trial of Treatment Intensification in Stage II-III Colon Cancer Patients with Positive MRD during Adjuvant ChemotherapyKCT0007644Seoul National University Hospital236
招募中
不适用
Circulating tumor DNA (ctDNA) analyses as a predictive marker for cancer treatment in solid tumorsKCT0008188Chonnam National University Hospital Hwasun Hospital100
尚未招募
不适用
Brain tumor biomarker studyCTRI/2021/01/030566Johns Hopkins University School of Medicine
招募中
不适用
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95